Last 12 months
Inside the activity.
0 purchase rows · 71 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 22 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 17 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 18 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 9, 2026 15:19 UTC |
Lu PengPresident
|
Exercise / conversionCommon Stock | 15,000 | $2.59 | $38,850.00 |
DisclosureSEC source: 0001193125-26-386096 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 15:49 UTC |
Modig BerndtDirector · Chief Executive Officer
|
SaleCommon Stock | 2,292 | $34.77 | $79,685.73 |
DisclosureSEC source: 0001193125-26-354965 · ownership.xml · nonDerivative · entry 1 Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,625 F1 · kind: The shares were acquired upon vesting of restricted stock units and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 20:35 UTC |
Lu PengPresident
|
Tax withholdingCommon Stock | 117 | $34.42 | $4,027.14 |
DisclosureSEC source: 0001193125-26-349371 · ownership.xml · nonDerivative · entry 2 Lu Peng · CIK 0001972159 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,179 F1 · shares: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:35 UTC |
Lu PengPresident
|
Tax withholdingCommon Stock | 109 | $34.84 | $3,797.56 |
DisclosureSEC source: 0001193125-26-349371 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,296 F1 · shares: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 17:08 UTC |
Modig BerndtDirector · Chief Executive Officer
|
SaleCommon Stock | 2,292 | $34.97 | $80,154.45 |
DisclosureSEC source: 0001193125-26-304445 · ownership.xml · nonDerivative · entry 1 Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,917 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $34.68 to $35.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 12, 2026 Filed Jul 14, 2026 19:46 UTC |
Lu PengChief Medical Officer
|
Tax withholdingCommon Stock | 117 | $35.07 | $4,103.19 |
DisclosureSEC source: 0001193125-26-303097 · ownership.xml · nonDerivative · entry 2 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,405 F1 · shares: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| July 11, 2026 Filed Jul 14, 2026 19:46 UTC |
Lu PengChief Medical Officer
|
Tax withholdingCommon Stock | 109 | $35.07 | $3,822.63 |
DisclosureSEC source: 0001193125-26-303097 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,522 F1 · shares: Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:06 UTC | SaleCommon Stock | 30,712 | $35.49 | $1,090,048.73 |
DisclosureSEC source: 0001193125-26-292962 · ownership.xml · nonDerivative · entry 2 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 315,167 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,972 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 16 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,972 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F10 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,900 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 13 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 24,900 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F9 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 30,703 | $35.49 | $1,089,637.19 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 11 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 93,969 F5 · kind: This is a scheduled sale from 10b5-1 trading plan. F8 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 27,872 | $35.48 | $988,890.20 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 9 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.84. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 24,900 | $8.05 | $200,445.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 8 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 2,972 | $2.59 | $7,697.48 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 7 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jun 29, 2026 22:18 UTC | SaleCommon Stock | 2,400 | $35.10 | $84,249.84 |
DisclosureSEC source: 0001193125-26-288840 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 352,767 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| June 29, 2026 Filed Jul 1, 2026 23:06 UTC | SaleCommon Stock | 6,888 | $35.05 | $241,447.13 |
DisclosureSEC source: 0001193125-26-292962 · ownership.xml · nonDerivative · entry 1 Schikan Johannes Gerardus Christiaan Petrus · CIK 0002014983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,879 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.10 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,100 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 15 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,972 Underlying: Common Stock · 4,100 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F10 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,400 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 14 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,072 Underlying: Common Stock · 1,400 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F10 · derivative.exercise_date: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,200 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · derivative · entry 12 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,900 Underlying: Common Stock · 4,200 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F9 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 6,997 | $35.05 | $245,231.56 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 10 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 124,672 F5 · kind: This is a scheduled sale from 10b5-1 trading plan. F6 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 8,300 | $35.05 | $290,907.53 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 6 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to 35.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 2,300 | $35.12 | $80,785.66 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 5 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 4,200 | $8.05 | $33,810.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 4 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 4,100 | $2.59 | $10,619.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 900 | $8.05 | $7,245.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:02 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 1,400 | $2.59 | $3,626.00 |
DisclosureSEC source: 0001193125-26-292956 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,700 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · derivative · entry 7 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,308 Underlying: Common Stock · 14,700 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F5 · derivative.exercise_date: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
SaleCommon Stock | 14,700 | $34.00 | $499,847.04 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · nonDerivative · entry 5 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,631 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $34.00 to 34.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
Exercise / conversionCommon Stock | 14,700 | $2.59 | $38,073.00 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · nonDerivative · entry 4 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,400 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · derivative · entry 6 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,072 Underlying: Common Stock · 1,400 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F5 · derivative.exercise_date: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 900 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · derivative · entry 5 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,100 Underlying: Common Stock · 900 shares Expires 2033-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F4 · derivative.exercise_date: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 2,300 | $35.12 | $80,785.66 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 4 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Indirect · By GrayMatters Consulting BVBA Disclosed balance after: 131,669 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC |
Lesage AnneChief Early Development
|
SaleCommon Stock | 2,300 | $35.12 | $80,774.62 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 3 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,450 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 900 | $8.05 | $7,245.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 2 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:41 UTC |
Lesage AnneChief Early Development
|
Exercise / conversionCommon Stock | 1,400 | $2.59 | $3,626.00 |
DisclosureSEC source: 0001193125-26-288863 · ownership.xml · nonDerivative · entry 1 Lesage Anne · CIK 0001973705 · Chief Early Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · derivative · entry 6 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,008 Underlying: Common Stock · 15,000 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F5 · derivative.exercise_date: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
SaleCommon Stock | 3,400 | $35.09 | $119,310.42 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · nonDerivative · entry 3 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,631 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to 35.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
SaleCommon Stock | 11,600 | $34.45 | $399,674.52 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · nonDerivative · entry 2 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,031 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $34.00 to $34.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:18 UTC |
Lu PengChief Medical Officer
|
Exercise / conversionCommon Stock | 15,000 | $2.59 | $38,850.00 |
DisclosureSEC source: 0001193125-26-288838 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:07 UTC |
Lu PengChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001193125-26-279753 · ownership.xml · derivative · entry 3 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,008 Underlying: Common Stock · 245,308 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. F2 · derivative.exercise_date: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:07 UTC |
Lu PengChief Medical Officer
|
SaleCommon Stock | 300 | $34.00 | $10,200.00 |
DisclosureSEC source: 0001193125-26-279753 · ownership.xml · nonDerivative · entry 2 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,631 F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:07 UTC |
Lu PengChief Medical Officer
|
Exercise / conversionCommon Stock | 300 | $2.59 | $777.00 |
DisclosureSEC source: 0001193125-26-279753 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise and sale from 10b5-1 trading plan. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:51 UTC |
Modig BerndtDirector · Chief Executive Officer
|
SaleCommon Stock | 100 | $31.46 | $3,146.00 |
DisclosureSEC source: 0001193125-26-274440 · ownership.xml · nonDerivative · entry 2 Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,209 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:51 UTC |
Modig BerndtDirector · Chief Executive Officer
|
SaleCommon Stock | 2,191 | $31.05 | $68,027.04 |
DisclosureSEC source: 0001193125-26-274440 · ownership.xml · nonDerivative · entry 1 Modig Berndt · CIK 0001643072 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,309 F1 · kind: This is a scheduled sale from 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.43 to $31.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 21:50 UTC |
Lu PengChief Medical Officer
|
Tax withholdingCommon Stock | 117 | $32.20 | $3,767.40 |
DisclosureSEC source: 0001193125-26-272978 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,631 F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on June 12, 2026. The shares were withheld on June 12, 2026 at a fair market value of $32.20 per share. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:22 UTC |
Lu PengChief Medical Officer
|
Tax withholdingCommon Stock | 109 | $31.51 | $3,434.59 |
DisclosureSEC source: 0001193125-26-271314 · ownership.xml · nonDerivative · entry 1 Lu Peng · CIK 0001972159 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,748 F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on June 11, 2026. The shares were withheld on June 11, 2026 at a fair market value of $31.51 per share. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 18:53 UTC |
Nijdam AnnaPrincipal Accounting Officer
|
SaleCommon Stock | 2,670 | $30.87 | $82,425.04 |
DisclosureSEC source: 0001193125-26-261316 · ownership.xml · nonDerivative · entry 1 Nijdam Anna · CIK 0001973872 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,275 F1 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.68 to $31.30 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2026 Filed May 26, 2026 21:45 UTC |
Nijdam AnnaPrincipal Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,501 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001193125-26-239733 · ownership.xml · derivative · entry 6 Nijdam Anna · CIK 0001973872 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,670 Underlying: Common Stock · 30,000 shares Expires 2031-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| May 22, 2026 Filed May 26, 2026 21:45 UTC |
Nijdam AnnaPrincipal Accounting Officer
|
SaleCommon Stock | 5,501 | $30.74 | $169,084.24 |
DisclosureSEC source: 0001193125-26-239733 · ownership.xml · nonDerivative · entry 4 Nijdam Anna · CIK 0001973872 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,945 F3 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $31.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2026 Filed May 26, 2026 21:45 UTC |
Nijdam AnnaPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 5,501 | $20.00 | $110,020.00 |
DisclosureSEC source: 0001193125-26-239733 · ownership.xml · nonDerivative · entry 3 Nijdam Anna · CIK 0001973872 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.